Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC)

Q1 2024 13F Holders as of 31 Mar 2024

Type / Class
Equity / COMMON STOCK
Shares outstanding
25,792,245
Total 13F shares
1,855
Share change
+1,855
Total reported value
$1,157
Price per share
$0.64
Number of holders
4
Value change
+$1,157
Number of buys
4

Institutional Holders of Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) as of Q1 2024

As of 31 Mar 2024, Cartesian Therapeutics, Inc. - COMMON STOCK (RNAC) was held by 4 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 1,855 shares. The largest 4 holders included WR Wealth Planners, LLC, Farther Finance Advisors, LLC, Parallel Advisors, LLC, and Avior Wealth Management, LLC. This page lists 4 institutional shareholders reporting positions in this security for the Q1 2024 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.